Science
Mosquito season is upon us. So why are Southern California officials releasing more of them?
Jennifer Castellon shook, tapped and blew on a box to shoo out more than 1,000 mosquitoes in a quiet, upscale Inland Empire neighborhood.
The insects had a job to do, and the pest scientist wanted every last one out.
Aggressive and impactful reporting on climate change, the environment, health and science.
Their task? Find lady mosquitoes and mate.
But these were no ordinary mosquitoes. Technicians had zapped the insects, all males, with radiation in a nearby lab to make them sterile. If they achieve their amorous quest, there will be fewer baby mosquitoes than there would be if nature ran its course. That means fewer mouths to feed — mouths that thirst for human blood.
“I believe, fingers crossed, that we can drop the population size,” said Solomon Birhanie, scientific director for the West Valley Mosquito and Vector Control District, which released the mosquitoes in several San Bernardino County neighborhoods this month.
Sterilized male Aedes mosquitoes are released from a box in Rancho Cucamonga.
(Myung J. Chun / Los Angeles Times)
Controlling mosquitoes with mosquitoes
Mosquito control agencies in Southern California are desperate to tamp down an invasive mosquito — called Aedes aegypti — that has exploded in recent years. Itchy, unhappy residents are demanding it. And the mosquitoes known for fierce ankle biting aren’t just putting a damper on outdoor hangouts — they also spread disease.
The low-flying, day-biting mosquitoes can lay eggs in tiny water sources. A bottle cap is fair game. And they might lay a few, say, in a plant tray and others, perhaps, in a drain. Tackling the invaders isn’t easy when it can be hard to even locate all the reproduction spots. So public health agencies increasingly are trying to use the insects’ own biology against them by releasing sterilized males.
The West Valley district, which covers six cities in San Bernardino County, rolled out the first program of this kind in California last year. Now they’re expanding it. Next month, a vector district covering a large swath of Los Angeles County will launch its own pilot, followed by Orange County in the near future. Other districts are considering using the sterile insect technique, as the method is known, or watching early adopters closely.
On the plus side, it’s an approach that doesn’t rely on pesticides, which mosquitoes become resistant to, but it requires significant resources and triggers conspiracy theories.
“People are complaining that they can’t go into their backyard or barbecue in the summer,” Birhanie said at his Ontario lab. “So we needed something to strengthen our Aedes control.” Of particular concern is the Aedes aegypti, which love to bite people — often multiple times in rapid succession.
Releasing sterilized male insects to combat pests is a proven scientific technique, but using it to control invasive mosquitoes is relatively new.
Vector control experts often point to the success of a decades-long effort in California to fight Mediterranean fruit flies by dropping enormous quantities of sterile males from small planes. That program, run by the U.S. Department of Agriculture and the California Department of Food and Agriculture, costs about $16 million a year. That’s nearly four times West Valley’s annual budget.
So rather than try to tackle every nook and cranny of the district, encompassing roughly 650,000 residents, West Valley decided to use a more targeted approach. If a problem area reaches a certain threshold — over 50 mosquitoes counted in an overnight trap — it becomes a candidate.
1
2
3
4
5
1. Solomon Birhanie inspects a container of mosquito larvae in the lab at the West Valley Mosquito and Vector Control District in Ontario. 2. Birhanie and his team raise mosquitoes in the lab, separating them by sex, because only the males, which don’t bite humans, will eventually be released. 3. Mosquito eggs in the West Valley lab. 4. The lab can grow about 10,000 mosquitoes at a time. 5. Before the male mosquitoes are released, an X-ray machine sterilizes them. If the zapped males mate with a female, her eggs won’t hatch. (Allen J. Schaben / Los Angeles Times)
And it’s still a big lift. About 10,000 mosquitoes are reared at a time at West Valley’s facility, about half of which will be males. The males are separated out, packed into cups and placed into an X-ray machine that looks like a small refrigerator. The sterilizing process isn’t that different from microwaving a frozen dinner. Zap them on a particular setting for four to five minutes and they’re good to go.
Equipment purchased for the program costs roughly $200,000, said Brian Reisinger, spokesperson for the district. He said it was too early to pin down a cost estimate for the program, which is expanding.
Some districts serving more people are going bigger.
The Greater Los Angeles County Vector Control District plans to unleash up to 60,000 mosquitoes a week in two neighborhoods in Sunland-Tujunga from mid-May through November.
With the sterile-insect program, “the biggest hurdle we’re up against really is scalability,” said Susanne Kluh, general manager of the L.A. County district, which is responsible for nearly 6 million residents across 36 cities.
In part to save money, Kluh’s district has partnered with the Orange County Mosquito and Vector Control District. They’re sharing equipment and collaborating on studies, but L.A. County’s releases will move forward first, said Brian Brannon, spokesperson for the O.C. district. Orange County expects to release its “ankle biter fighters,” as Brannon called them, in Mission Viejo this fall or next spring.
So far, the L.A. County district has shelled out about $255,000 for its pilot, while O.C. has spent around $160,000. It’s a relatively small portion of their annual budgets: L.A. at nearly $25 million and O.C. at $17 million. But the area they’re targeting is modest.
Mosquito control experts tout sterilization for being environmentally friendly because it doesn’t involve spraying chemicals, and it may have a longer-lasting effectiveness than pesticides. It can also be done now. Other methods involving genetically modified mosquitoes and ones infected with bacteria are stuck in an approval process that spans federal and state agencies. One technique, involving the bacteria Wolbachia was recently approved by the Environmental Protection Agency and is now heading to the California Department of Pesticide Regulation to review, said Jeremy Wittie, general manager for the Coachella Valley Mosquito and Vector Control District.
“Using pesticides or insecticides, resistance crops up very quickly,” said Nathan Grubaugh, associate professor of epidemiology at the Yale School of Public Health.
Vector control experts hope the fact that the sterilization technique doesn’t involve genetic modification will tamp down conspiracy theories that have cropped up around mosquito releases. One erroneous claim is that a Bill Gates-backed effort to release mosquitoes was tied to malaria cases in Florida and Texas. Reputable outlets debunked the conspiracy theory, pointing out that Gates’ foundation didn’t fund the Florida project and that the type of mosquito released (Aedes) does not transmit malaria.
To get ahead of concerns, districts carrying out the releases say they’ve engaged in extensive outreach and education campaigns. Residents’ desire to rid themselves of a scourge may overcome any anxieties.
“I think if you have the choice of getting eaten alive by ankle biters or having a DayGlo male X-rayed mosquito come by looking for a female to not have babies with, you’d probably go for the latter,” Brannon said. (“DayGlo” is a riff on the fluorescent pigment product of the same name — the sterilized mosquitoes were dusted with bright colors to help identify them.)
Sterilized male mosquitoes buzz around vector ecologist Jennifer Castellon as they are released in Rancho Cucamonga earlier this month.
(Myung J. Chun / Los Angeles Times)
Disease at our doorstep
As the climate warms and some regions become wetter, dengue is expanding to areas it’s never been seen before — and surging in areas where it’s established. Florida has seen alarming spikes in the viral infection in recent years, and Brazil and Puerto Rico are currently battling severe outbreaks. While most people infected with dengue have no symptoms, it can cause severe body aches and fever and, in rare cases, death. Its alias, “breakbone fever,” provides a grim glimpse into what it can feel like.
In October of last year, the city of Pasadena announced the Golden State’s first documented locally transmitted case of dengue, describing it as “extremely rare” in a news release. That same month, a second case was confirmed in Long Beach. Local transmission means the patient hadn’t traveled to a region where dengue is common; they may have been bitten by a mosquito carrying the disease in their own neighborhood.
Surging dengue abroad means there’s more opportunity for travelers to bring it home. However, Grubaugh said it doesn’t seem that California is imminently poised for a “Florida-like situation,” where there were nearly 1,000 cases in 2022, including 60 that were locally acquired. Southern California in particular lacks heavy rainfall that mosquitoes like, he said. But some vector experts believe more locally acquired cases are inevitable.
Ale Macias releases sterilized male mosquitoes in Upland this month.
(Myung J. Chun / Los Angeles Times)
Set them free
In mid-April, a caravan of staffers from the West Valley district traveled to five mosquito “hot spots” in Chino, Upland and Rancho Cucamonga — where data showed mosquito levels were particularly high — to release their first batches of sterilized male mosquitoes for the year. Peak Aedes season is months away, typically August to October in the district, and Birhanie said that’s the point. The goal is to force down the numbers to prevent an itchy tsunami later.
Males don’t bite, so the releases won’t lead to more inflamed welts. But residents might notice more insects in the air. Sterilized males released by West Valley will outnumber females in the wild by at least 100 to 1 to increase their chances of beating out unaltered males, spokeperson Reisinger said.
“They’re not going to be contributing to the biting pressure; they’re just going to be looking for love,” as Reisinger put it.
Eggs produced by a female after a romp with a sterile male don’t hatch. And female mosquitoes typically mate only once, meaning all her eggs are spoiled, so to speak. Vector experts say the process drives down the population over time.
Interestingly, the hot spots were fairly spread out across the district, indicative of the bloodsuckers’ widespread presence and adaptive nature. A picturesque foothills community in Upland was “especially interesting” because of its relatively high elevation, Birhanie said.
It was once inhabited primarily by another invasive mosquito that prefers colder, mountainous climates. Construction and deforestation in the area has literally paved the way for its humidity- and heat-loving brethren to move in.
Another neighborhood, in Rancho Cucamonga, posed a mystery. For the last two years, mosquito levels were consistently high. Door-to-door inspections, confoundingly, didn’t reveal the source.
“That’s one of the things about invasive Aedes mosquitoes — you can’t find them,” he said.
Next steps
Some vector control experts want to see a regional approach to sterile mosquito releases, similar to the state Medfly program.
Jason Farned, district manager for the San Gabriel Valley Mosquito and Vector Control District, believes a widespread effort “would be much more effective” and thinks that will come in time.
There are no talks underway to make it happen, and it’s not yet clear how it would work. Vector control agencies are set up to serve their local communities.
Fears of a bad mosquito year ahead are bubbling as the weather warms. Rain — which there was plenty of this spring — can quickly transform into real estate for mosquito reproduction.
When the swarms come, mosquito haters can take typical precautions: dump standing water and wear repellent. And they can root for the sterile males to get lucky.
Science
What’s in a Name? For These Snails, Legal Protection
The sun had barely risen over the Pacific Ocean when a small motorboat carrying a team of Indigenous artisans and Mexican biologists dropped anchor in a rocky cove near Bahías de Huatulco.
Mauro Habacuc Avendaño Luis, one of the craftsmen, was the first to wade to shore. With an agility belying his age, he struck out over the boulders exposed by low tide. Crouching on a slippery ledge pounded by surf, he reached inside a crevice between two rocks. There, lodged among the urchins, was a snail with a knobby gray shell the size of a walnut. The sight might not dazzle tourists who travel here to see humpback whales, but for Mr. Avendaño, 85, these drab little mollusks represent a way of life.
Marine snails in the genus Plicopurpura are sacred to the Mixtec people of Pinotepa de Don Luis, a small town in southwestern Oaxaca. Men like Mr. Avendaño have been sustainably “milking” them for radiant purple dye for at least 1,500 years. The color suffuses Mixtec textiles and spiritual beliefs. Called tixinda, it symbolizes fertility and death, as well as mythic ties between lunar cycles, women and the sea.
The future of these traditions — and the fate of the snails — are uncertain. The mollusks are subject to intense poaching pressure despite federal protections intended to protect them. Fishermen break them (and the other mollusks they eat) open and sell the meat to local restaurants. Tourists who comb the beaches pluck snails off the rocks and toss them aside.
A severe earthquake in 2020 thrust formerly submerged parts of their habitat above sea level, fatally tossing other mollusks in the snail’s food web to the air, and making once inaccessible places more available to poachers.
Decades ago, dense clusters of snails the size of doorknobs were easy to find, according to Mr. Avendaño. “Full of snails,” he said, sweeping a calloused, violet-stained hand across the coves. Now, most of the snails he finds are small, just over an inch, and yield only a few milliliters of dye.
Science
Video: This Parrot Has No Beak, But Is at the Top of the Pecking Order
new video loaded: This Parrot Has No Beak, But Is at the Top of the Pecking Order
By Meg Felling and Carl Zimmer
April 20, 2026
Science
Contributor: Focus on the real causes of the shortage in hormone treatments
For months now, menopausal women across the U.S. have been unable to fill prescriptions for the estradiol patch, a long-established and safe hormone treatment. The news media has whipped up a frenzy over this scarcity, warning of a long-lasting nationwide shortage. The problem is real — but the explanations in the media coverage miss the mark. Real solutions depend on an accurate understanding of the causes.
Reporters, pharmaceutical companies and even some doctors have blamed women for causing the shortage, saying they were inspired by a “menopause moment” that has driven unprecedented demand. Such framing does a dangerous disservice to essential health advocacy.
In this narrative, there has been unprecedented demand, and it is explained in part by the Food and Drug Administration’s recent removal of the “black-box warning” from estradiol patches’ packaging. That inaccurate (and, quite frankly, terrifying) label had been required since a 2002 announcement overstated the link between certain menopause hormone treatments and breast cancer. Right-sizing and rewording the warning was long overdue. But the trouble with this narrative is that even after the black-box warning was removed, there has not been unprecedented demand.
Around 40% of menopausal women were prescribed hormone treatments in some form before the 2002 announcement. Use plummeted in its aftermath, dipping to less than 5% in 2020 and just 1.8% in 2024. According to the most recent data, the number has now settled back at the 5% mark. Unprecedented? Hardly. Modest at best.
Nor is estradiol a new or complex drug; the patch formulation has existed for decades, and generic versions are widely manufactured. There is no exotic ingredient, no rare supply chain dependency, no fluke that explains why women are suddenly being told their pharmacy is out of stock month after month.
The story is far more an indictment of the broken insurance industry: market concentration, perverse incentives and the consequences of allowing insurance companies to own the pharmacy benefit managers that effectively control drug access for the majority of users. Three companies — CVS Caremark, Express Scripts and OptumRx — manage 79% of all prescription drug claims in the United States. Those companies are wholly owned subsidiaries of three insurance behemoths: CVS Health, Cigna and UnitedHealth Group, respectively. This means that the same corporation that sells you your insurance plan also decides which drugs get covered, at what price, and whether your pharmacy can stock them. This is called vertical integration. In another era, we might have called it a cartel. The resulting problems are not unique to hormone treatments; they have affected widely used medications including blood thinners, inhalers and antibiotics. When a low-cost generic such as estradiol — a medication with no blockbuster profit margins and no patent protection — runs into friction in this system, the friction is not random. It is structural. Every decision in that chain is filtered through the same corporate profit motive. And when the drug in question is an off-patent estradiol patch that has negligible profit margins because of generic competition but requires logistical investment to keep consistently in stock? The math on “how much does this company care about ensuring access” is not complicated.
Unfortunately, there is little financial incentive to ensure smooth, consistent access. There is, however, significant financial incentive to steer patients toward branded alternatives, or simply to let supply tighten — because the companies aren’t losing much profit if sales of that product dwindle. This is not a conspiracy theory: The Federal Trade Commission noted this dynamic in a report that documented how pharmacy benefit managers’ practices inflate costs, reduce competition and harm patient access, particularly for independent pharmacies and for generic drugs.
Any claim that the estradiol patch shortage is meaningfully caused by more women now demanding hormone treatments is a distraction. It is also misogyny, pure and simple, to imply that the solution to the shortage is for women’s health advocates to dial it down and for women to temper their expectations. The scarcity of estradiol patches is the outcome of a broken system refusing to provide adequate supply.
Meanwhile, there are a few strategies to cope.
- Ask your prescriber about alternatives. Estradiol is available in multiple formulations, including gel, spray, cream, oral tablet, vaginal ring and weekly transdermal patch, which is a different product from the twice-weekly patch and may be more consistently available depending on manufacturer and region.
- Consider an online pharmacy. Many are doing a good job locating and filling these prescriptions from outside the pharmacy benefit manager system.
- Call ahead. Patch shortages are inconsistent across regions and distributors. A call to pharmacies in your area, or a broader geographic radius if you’re able, can locate stock that your regular pharmacy doesn’t have.
- Consider a compounding pharmacy. These sources can sometimes meet needs when commercially manufactured products are inaccessible. The hormones used are the same FDA-regulated bulk ingredients.
Beyond those Band-Aid solutions, more Americans need to fight for systemic change. The FTC report exists because Congress asked for it and committed to legislation that will address at least some of the problems. The FDA took action to change the labeling on estrogen in the face of citizen and medical experts’ pressure; it should do more now to demand transparency from patch manufacturers.
Most importantly, it is on all of us to call out the cracks in the current system. Instead of repeating “there’s a patch shortage” or a “surge in demand,” say that a shockingly small minority of menopausal women still even get hormonal treatments prescribed at all, and three drug companies control the vast majority of claims in this country. Those are the real problems that need real solutions.
Jennifer Weiss-Wolf, the executive director of the Birnbaum Women’s Leadership Center at New York University School of Law, is the author of the forthcoming book “When in Menopause: A User’s Manual & Citizen’s Guide.” Suzanne Gilberg, an obstetrician and gynecologist in Los Angeles, is the author of “Menopause Bootcamp.”
-
Arizona3 minutes agoPilot Jessica Cox to be inducted into Arizona Aviation Hall of Fame
-
Arkansas9 minutes agoEffort to cut former Arkansas corrections secretary’s position as adviser to governor fails – Arkansas Times
-
California15 minutes agoCalifornia sees lowest number of firearm-related deaths since 1968, new data shows
-
Colorado21 minutes agoSouthern Colorado farmers’ market season is here
-
Connecticut27 minutes agoAmtrak won’t close shoreline rail bridges during World Cup, reversing earlier proposal
-
Delaware33 minutes agoLucky Duck a new destination on the Delaware River waterfront
-
Georgia45 minutes ago2026 NFL Draft Scouting Report — Christen Miller, DT, Georgia
-
Hawaii51 minutes ago
Iran War Puts a Pause on Hawaii’s Housing Market Recovery